Skip to Main Content

Author Details

Magdalena Korecka
Perelman School of Medicine, University of Pennsylvania
1998
47
30
PMIDPaper TitleJournal TitlePublished Year
37725909Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology.Clin Chem2023
34906975Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques.Neurology2022
34244999Mass spectrometry-based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids.J Neurochem2021
34692980The global Alzheimer's Association round robin study on plasma amyloid β methods.Alzheimers Dement (Amst)2021
32755010First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.Alzheimers Dement2020
32087019Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC-MS/MS Reference Method.Clin Chem2020
31848218Detection of Alzheimer Disease Pathology in Patients Using Biochemical Biomarkers: Prospects and Challenges for Use in Clinical Practice.J Appl Lab Med2020
32913021Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trial.Neurology2020
30426066Derivation of cutoffs for the Elecsys<sup>®</sup> amyloid β (1-42) assay in Alzheimer's disease.Alzheimers Dement (Amst)2018
27216941CSF Aβ<sub>1-42</sub> - an excellent but complicated Alzheimer's biomarker - a route to standardisation.Clin Chim Acta2017
26206625Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.Alzheimers Dement2016
27472882Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.J Alzheimers Dis2016
26194312The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.Alzheimers Dement2015
24625802Qualification of a surrogate matrix-based absolute quantification method for amyloid-β⿿⿿ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.J Alzheimers Dis2014
25037769History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.Drug Alcohol Depend2014
23519967Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and Ͽ proteins as Alzheimer disease biomarkers.Clin Chem2013
22343285Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Proc Natl Acad Sci U S A2012
22748936Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients.Alzheimers Dement2012
21743385Evaluation of performance of new, isotopically labeled internal standard ([13c2d4]RAD001) for everolimus using a novel high-performance liquid chromatography tandem mass spectrometry method.Ther Drug Monit2011
20077099Quantitation of sirolimus using liquid chromatography-tandem mass spectrometry (LC-MS-MS).Methods Mol Biol2010
20451871Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.Alzheimers Dement2010
20643588Simultaneous HPLC-MS-MS quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and brain tissue samples with on-line cleanup.J Chromatogr B Analyt Technol Biomed Life Sci2010
19005875Prenatal dexamethasone exposure in the common marmoset monkey enhances gene expression of antioxidant enzymes in the aorta of adult offspring.Stress2009
19809389High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.Ther Drug Monit2009
19487797Review of the newest HPLC methods with mass spectrometry detection for determination of immunosuppressive drugs in clinical practice.Ann Transplant2009
17259231HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma.Clin Chem2007
17347655Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.Nat Rev Drug Discov2007
16885715Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement.Ther Drug Monit2006
15257062Using established immunosuppressant therapy effectively: lessons from the measurement of mycophenolic acid plasma concentrations.Ther Drug Monit2004
15570196Accidental intravenous colchicine poisoning.Ther Drug Monit2004
12752309Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.Am J Transplant2003
12777861Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses.Transplantation2003
11805725Monitoring of mycophenolic acid in clinical transplantation.Ther Drug Monit2002
12200787Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report.Liver Transpl2002
12194926Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.Clin Chem2002
11239510Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.Clin Biochem2001
10688251Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation.Ther Drug Monit2000
10868313Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable.J Clin Pharmacol2000
11077224Mycophenolic acid concentrations are associated with cardiac allograft rejection.J Heart Lung Transplant2000
10759564The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders.Proc Natl Acad Sci U S A2000
10688253Pharmacokinetics of mycophenolic acid in renal insufficiency.Ther Drug Monit2000
10388481The apparent inhibition of inosine monophosphate dehydrogenase by mycophenolic acid glucuronide is attributable to the presence of trace quantities of mycophenolic acid.Clin Chem1999
10229324Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.Leuk Res1999
10392326The effect of renal insufficiency on mycophenolic acid protein binding.J Clin Pharmacol1999
9721429Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid.Clin Biochem1998
9723454Scientific principles for mycophenolic acid therapeutic drug monitoring.Transplant Proc1998
9549665Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function.J Clin Pharmacol1998
  • 1 - 47 of 47

Recommended Authors

Pajaree Chariyavilaskul
Chulalongkorn University
Career Start Year 2013
Number of shared co-authors 0
Joe M El-Khoury
Yale School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Joely A Straseski
University of Utah Health Sciences Center
Career Start Year 2009
Number of shared co-authors 0
Dustin R Bunch
Nationwide Children's Hospital, College of Medicine, The Ohio State University
Career Start Year 2008
Number of shared co-authors 0
Ioannis Prassas
Mount Sinai Hospital
Career Start Year 2007
Number of shared co-authors 1
Kara L Lynch
University of California San Francisco
Career Start Year 2006
Number of shared co-authors 0
Bradley L Urquhart
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 0
Kyunghoon Lee
Seoul National University Bundang Hospital and College of Medicine
Career Start Year 2002
Number of shared co-authors 0
Melinda Rezeli
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 0
Shannon Haymond
Ann Robert H. Lurie Childrens Hospital of Chicago
Career Start Year 2000
Number of shared co-authors 0
Peter Horvatovich
Groningen Research Institute of Pharmacy, University of Groningen
Career Start Year 1999
Number of shared co-authors 0
Viswanath Devanarayan
Clinical Evidence Generation, Eisai Inc.
Career Start Year 1999
Number of shared co-authors 1
??kos V??gv??ri
Karolinska Institutet
Career Start Year 1998
Number of shared co-authors 0
Douglas Hayden
Massachusetts General Hospital.
Career Start Year 1997
Number of shared co-authors 3
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 0
Nathan A Yates
University of Pittsburgh School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Alain Pruvost
Universite Paris Saclay
Career Start Year 1994
Number of shared co-authors 0
Christoph H Borchers
McGill University
Career Start Year 1994
Number of shared co-authors 0
Saeed A Jortani
University of Louisville
Career Start Year 1991
Number of shared co-authors 0
Ronald C Hendrickson
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 0
Andrea Urbani
National Research Council (CNR)
Career Start Year 1990
Number of shared co-authors 1
Oliver Kretz
University Medical Center Hamburg-Eppendorf
Career Start Year 1989
Number of shared co-authors 0
Robert L Fitzgerald
university of california san diego Health, Center for Advanced Laboratory Medicine
Career Start Year 1988
Number of shared co-authors 0
Terry M Therneau
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 2
Stephen Naylor
ReNeuroGen LLC
Career Start Year 1985
Number of shared co-authors 0
Rainer Bischoff
Groningen Research Institute of Pharmacy, University of Groningen
Career Start Year 1982
Number of shared co-authors 0
Lawrence J Lesko
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 0
Alan H B Wu
University of California san francisco
Career Start Year 1979
Number of shared co-authors 2
George G Klee
Mayo Clinic
Career Start Year 1974
Number of shared co-authors 0
Susan T Weintraub
University of Texas Health Science Center at San Antonio Texas78229 USA.
Career Start Year 1973
Number of shared co-authors 1

Collaborators

Leslie M Shaw
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 44
John Q Trojanowski
University of Pennsylvania
Co-authored papers 13
Michael W Weiner
University of California San Francisco
Co-authored papers 6
Virginia M-Y Lee
Perelman School of Medicine at the University of Pennsylvania
Co-authored papers 5
William J Jagust
Helen Wills Neuroscience Institute, University of California Berkeley
Co-authored papers 3
Ronald C Petersen
Mayo Clinic Rochester
Co-authored papers 3
Paul S Aisen
Alzheimer's Therapeutic Research Institute, University of Southern California
Co-authored papers 3
Andrew J Saykin
Indiana University School of Medicine
Co-authored papers 2
Steven E Arnold
Massachusetts General Hospital
Co-authored papers 2
Arthur W Toga
Keio University School of Medicine
Co-authored papers 2
Clifford R Jack
Mayo Clinic Rochester
Co-authored papers 2
David A Wolk
University of Pennsylvania
Co-authored papers 2
Robert Bartha
The University of Western Ontario
Co-authored papers 1
Lawrence S Honig
University of California
Co-authored papers 1
John C Morris
Washington University School of Medicine
Co-authored papers 1
Oscar L Lopez
University of Pittsburgh
Co-authored papers 1
Po H Lu
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Stanley Thomas Carmichael
David Geffen School of Medicine at University of California-Los Angeles
Co-authored papers 1
Hilda Rizzo-Busack
Co-authored papers 1
Ranjan Duara
Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center
Co-authored papers 1
Dana Mathews
University of Texas Southwestern Medical Center
Co-authored papers 1
Nancy Johnson
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Sandra A Jacobson
University of Arizona College of Medicine
Co-authored papers 1
Smita Kittur
SUNY Upstate Medical University
Co-authored papers 1
Richard Frank
Siemens Healthineers North America, Siemens Medical Solutions USA
Co-authored papers 1
Ging-Yuek
Co-authored papers 1
Danielle Harvey
University of California davis
Co-authored papers 1
Rachelle S Doody
F. Hoffmann-La Roche Ltd
Co-authored papers 1
Tal Kenet
Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
Co-authored papers 1
Laurel A Beckett
University of California davis
Co-authored papers 1
Release 1.2